JP2005145932A5 - - Google Patents

Download PDF

Info

Publication number
JP2005145932A5
JP2005145932A5 JP2003389640A JP2003389640A JP2005145932A5 JP 2005145932 A5 JP2005145932 A5 JP 2005145932A5 JP 2003389640 A JP2003389640 A JP 2003389640A JP 2003389640 A JP2003389640 A JP 2003389640A JP 2005145932 A5 JP2005145932 A5 JP 2005145932A5
Authority
JP
Japan
Prior art keywords
inflammatory analgesic
mol
local anesthetic
external preparation
less
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003389640A
Other languages
Japanese (ja)
Other versions
JP2005145932A (en
Filing date
Publication date
Application filed filed Critical
Priority to JP2003389640A priority Critical patent/JP2005145932A/en
Priority claimed from JP2003389640A external-priority patent/JP2005145932A/en
Publication of JP2005145932A publication Critical patent/JP2005145932A/en
Publication of JP2005145932A5 publication Critical patent/JP2005145932A5/ja
Pending legal-status Critical Current

Links

Claims (6)

アリール酢酸系非ステロイド消炎鎮痛剤および局所麻酔剤を含有する消炎鎮痛剤であって、当該アリール酢酸系非ステロイド消炎鎮痛剤の含有量が、当該消炎鎮痛剤全体に対して５質量％以上、５０質量％以下であることを特徴とする消炎鎮痛外用剤。 An anti-inflammatory analgesic agent comprising an aryl acetic acid-based nonsteroidal anti-inflammatory analgesic and a local anesthetic, wherein the content of the aryl acetic acid-based non-steroidal anti-inflammatory analgesic is 5% by mass or more , 50 % An anti-inflammatory analgesic external preparation characterized by having a mass% or less . 上記アリール酢酸系非ステロイド消炎鎮痛剤１モルに対して、上記局所麻酔剤が０．７モル以上、１．３モル以下の比で混合されている請求項１に記載の消炎鎮痛外用剤。The anti-inflammatory analgesic external preparation according to claim 1, wherein the local anesthetic is mixed in a ratio of 0.7 mol or more and 1.3 mol or less with respect to 1 mol of the arylacetic acid-based nonsteroidal anti-inflammatory analgesic. 上記アリール酢酸系非ステロイド消炎鎮痛剤の含有量が、上記消炎鎮痛剤全体に対して２０質量％以下である請求項１または２に記載の消炎鎮痛外用剤。The anti-inflammatory analgesic external preparation according to claim 1 or 2, wherein the content of the arylacetic acid-based nonsteroidal anti-inflammatory analgesic is 20% by mass or less based on the total anti-inflammatory analgesic. 上記局所麻酔剤が、リドカインまたはその塩である請求項１〜３の何れか１項に記載の消炎鎮痛外用剤。 The anti-inflammatory analgesic external preparation according to any one of claims 1 to 3 , wherein the local anesthetic is lidocaine or a salt thereof. アリール酢酸系非ステロイド消炎鎮痛剤１モルに対して局所麻酔剤を０．７モル以上、１．３モル以下の比で含む均一組成物を含有することを特徴とする、当該非ステロイド消炎鎮痛剤の皮膚への浸透拡散促進剤。A non-steroidal anti-inflammatory analgesic comprising a uniform composition containing a local anesthetic in a ratio of 0.7 mol or more and 1.3 mol or less with respect to 1 mol of an arylacetic acid-based non-steroidal anti-inflammatory analgesic Penetration enhancer for skin. 上記局所麻酔剤が、リドカインまたはその塩である請求項５に記載の浸透拡散促進剤。The osmotic diffusion enhancer according to claim 5, wherein the local anesthetic is lidocaine or a salt thereof.
JP2003389640A 2003-11-19 2003-11-19 Antiinflammatory analgesic agent for external use Pending JP2005145932A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2003389640A JP2005145932A (en) 2003-11-19 2003-11-19 Antiinflammatory analgesic agent for external use

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2003389640A JP2005145932A (en) 2003-11-19 2003-11-19 Antiinflammatory analgesic agent for external use

Publications (2)

Publication Number Publication Date
JP2005145932A JP2005145932A (en) 2005-06-09
JP2005145932A5 true JP2005145932A5 (en) 2007-01-11

Family

ID=34696328

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003389640A Pending JP2005145932A (en) 2003-11-19 2003-11-19 Antiinflammatory analgesic agent for external use

Country Status (1)

Country Link
JP (1) JP2005145932A (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100029704A1 (en) * 2007-01-29 2010-02-04 Medrx Co., Ltd. Salt of nonsteroidal anti-inflammatory drug and organic amine compound and use thereof
JP2009298741A (en) 2008-06-16 2009-12-24 Teikoku Seiyaku Co Ltd Anti-inflammatory analgesic external preparation
JP5564241B2 (en) 2009-12-15 2014-07-30 帝國製薬株式会社 Percutaneous absorption preparation containing felbinac
US20120322840A1 (en) 2009-12-15 2012-12-20 Teikoku Seiyaku Co., Ltd. Transdermally Absorbable Preparation Containing Basic Anti-Inflammatory Analgesic
JP5748346B2 (en) 2009-12-15 2015-07-15 帝國製薬株式会社 Piroxicam-containing transdermal absorption preparation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000038352A (en) * 1998-07-24 2000-02-08 Lion Corp Composition for external use
JP2000229852A (en) * 1999-02-04 2000-08-22 Lion Corp Skin lotion
EP1170020A4 (en) * 1999-12-27 2009-05-06 Teikoku Seiyaku Kk Patches for external use
JP2002020316A (en) * 2000-06-30 2002-01-23 Lion Corp Percutaneous absorbefacient, trans mucosa absorbefacient

Similar Documents

Publication Publication Date Title
JP2011500711A5 (en)
JP2009545372A5 (en)
JP2009516719A5 (en)
EP2380564A3 (en) An oral pharmaceutical composition
CA2554751A1 (en) Anti-inflammatory analgesic for external use
DK1315477T3 (en) Dry powder composition with film-forming properties
SV2008002612A (en) DOSAGE FORM OF ORAL DELAYED ORAL DESEMTILVANLAFAXINA DELAYED ORAL DELIVERY RELEASE REF. AM101721SALVO
JP2006517944A5 (en)
JP2005145932A5 (en)
TW200714293A (en) Pharmaceutical composition containing hardly water souble pharmaceutical substance
MX2007005121A (en) Composition comprising acetaminophen, caffeine and optionally aspirin together with an alkiline agent fr enhanced absorption.
CA2599334A1 (en) External plaster containing flurbiprofen
WO2009061482A3 (en) Anesthetic composition, formulation and method of use
JP2005145931A5 (en)
JP2005097259A5 (en)
BR0317924A (en) Non-aqueous dosage forms of prostaglandin compound and
JP2005522546A5 (en)
RU2005123045A (en) POWDER PHARMACEUTICAL COMPOSITIONS AND METHODS OF TREATMENT
JP2005511708A5 (en)
JP2002179518A5 (en)
ATE322259T1 (en) TOPICAL COMPOSITION CONTAINING KETOPROFEN STABILIZED WITH SULISOBENZONE
JP2005511285A5 (en)
WO2003061684A3 (en) Tumour treatment compositions comprising hsp70 and tumour necrosis factor
JP2005145930A5 (en)
JP2004100059A5 (en)